Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Real-world Study in Participants With Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT06472778. IPD Sharing: NO. Countries: 5. Publications: 0.
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat
ClinicalTrials.gov study NCT04150289. IPD Sharing: NO. Countries: 1. Publications: 0.
APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04657861. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
ClinicalTrials.gov study NCT01440556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03136653. IPD Sharing: NO. Countries: 6. Publications: 0.
Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease
ClinicalTrials.gov study NCT00002652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT03631043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05448196. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00402181. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06375044. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02072863. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability
ClinicalTrials.gov study NCT00257114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pseudohyponatremia of Multiple Myeloma is True Hyponatremia
ClinicalTrials.gov study NCT01425606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stage I Multiple Myeloma Treatment
ClinicalTrials.gov study NCT00733538. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
ClinicalTrials.gov study NCT06052826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04318327. IPD Sharing: NO. Countries: 4. Publications: 0.
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
ClinicalTrials.gov study NCT03710421. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)
ClinicalTrials.gov study NCT05632380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06381141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01470131. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.